Free tool
FAERS Monitor: Palonosetron Hydrochloride
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 207963 or its brand name (Palonosetron Hydrochloride, Palonosetron Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
1,801
Serious
1,727
96% of reports
Hospitalization
984
Death reported
354
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea169
- neutrophil count decreased151
- off label use144
- anaemia118
- pyrexia113
- white blood cell count decreased112
- diarrhoea108
- platelet count decreased108
- vomiting100
- decreased appetite95
- myelosuppression93
- death88
- febrile neutropenia85
- pneumonia85
- fatigue82
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 5 |
| 2005 | 8 |
| 2006 | 7 |
| 2007 | 4 |
| 2009 | 8 |
| 2010 | 14 |
| 2011 | 16 |
| 2012 | 58 |
| 2013 | 33 |
| 2014 | 41 |
| 2015 | 52 |
| 2016 | 103 |
| 2017 | 63 |
| 2018 | 105 |
| 2019 | 72 |
| 2020 | 108 |
| 2021 | 194 |
| 2022 | 218 |
| 2023 | 237 |
| 2024 | 159 |
| 2025 | 196 |
| 2026 | 100 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,358 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| neutrophil count decreasedSignal | 151 | 43.4 | 37.3 | 6,205 |
| myelosuppressionSignal | 93 | 30.2 | 24.8 | 2,597 |
| febrile neutropeniaSignal | 85 | 15.0 | 12.2 | 1,097 |
| white blood cell count decreasedSignal | 112 | 12.1 | 10.1 | 1,132 |
| platelet count decreasedSignal | 108 | 11.8 | 9.9 | 1,066 |
| anaemiaSignal | 118 | 7.2 | 6.1 | 633 |
| decreased appetiteSignal | 95 | 4.8 | 3.9 | 283 |
| pyrexiaSignal | 113 | 3.8 | 3.2 | 236 |
| pneumoniaSignal | 85 | 3.1 | 2.5 | 118 |
| nauseaSignal | 169 | 2.5 | 2.2 | 156 |
| vomitingSignal | 100 | 2.5 | 2.1 | 89 |
| diarrhoea | 108 | 2.0 | 1.6 | 51 |
| off label use | 144 | 1.9 | 1.6 | 65 |
| fatigue | 82 | 1.2 | 1.0 | 3 |
| death | 88 | 1.2 | 1.0 | 3 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.